Efficacy and Safety of Nitazoxanide in Preventing Recurrence of Hepatic Encephalopathy
ConditionHepatic Encephalopathy
Trial statusRecruiting
Trial phasePhase 3
Trial typeInterventional
Biological sexAll
Age20-65
SponsorTanta University
About this trial
Efficacy and Safety of Nitazoxanide in preventing recurrence of Hepatic Encephalopathy.
Eligibility criteria
Qualifiers
Cirrhotic patient with at least one previous episode of hepatic encephalopathy.
Adult Patients aging from 20 to 65 years old
Disqualifiers
Active GIT bleeding.
Major psychiatric illness (psychosis & epilepsy).
Renal insufficiency (S.Cr 2mg/dl).
Trial design
Treatments tested in this trial
- Rifaximin
- Nitazoxanide
Treatment groups
60 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov